AstraZeneca and MedImmune present positive immuno-oncology combination data at ASCO 2015
AstraZeneca and MedImmune, the company’s global biologics research and development arm, today presented encouraging results from their novel combination-focused immuno-oncology portfolio at the American...
Guangzhou Medical University & AstraZeneca: Advancing understanding of COPD in China
We’re working with Guangzhou Medical University, one of the world’s leading centres for research into respiratory disease, to advance the scientific understanding of Chronic...
AstraZeneca is proud to support a new Insight by Nature on precision medicine
AstraZeneca is proud to support a new Insight by Nature on precision medicine. Currently, 80% of our pipeline takes a precision medicine, or personalised...
AstraZeneca opens new manufacturing facility to support continued growth in Russia
AstraZeneca today announced the opening of its new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines....
Hillary Clinton Proposes $250 Monthly Cap on Prescription Drug Costs
Democratic presidential candidate Hillary Clinton proposed on Tuesday a $250 monthly cap on out-of-pocket prescription drug costs and other measures to stop what she...
UPDATE 3-Drug maker Novo Nordisk to build $78 mln plant in Iran
Danish drug maker Novo Nordisk will invest 70 million euros ($78 million) to build a manufacturing plant in Iran, joining a small group of...
Takeda Submits a New Drug Application for the Fixed-Dose Combination of Nesina® and Metformin Hydrochloride for the Treatment of Type 2 Diabetes in Japan
Takeda Pharmaceutical Company Limited ("Takeda") (TSE: 4502) announced today that it has submitted a New Drug Application ("NDA") to the Ministry of Health, Labor...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...